Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-21
DOI
10.3389/fonc.2020.01378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inflammation and cancer: tissue regeneration gone awry
- (2016) Marina Pesic et al. CURRENT OPINION IN CELL BIOLOGY
- Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells
- (2016) Hong Wang et al. EXPERIMENTAL CELL RESEARCH
- Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer
- (2016) Zibing Wang et al. Journal of Hematology & Oncology
- 3,4-Methylenedioxy-β-Nitrostyrene Ameliorates Experimental Burn Wound Progression by Inhibiting the NLRP3 Inflammasome Activation
- (2016) Mengjing Xiao et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- L’inflammasome NLRP3 : physiopathologie et application thérapeutique
- (2016) Thomas Gicquel et al. PRESSE MEDICALE
- Mechanism and Regulation of NLRP3 Inflammasome Activation
- (2016) Yuan He et al. TRENDS IN BIOCHEMICAL SCIENCES
- The inflammasome: an emerging therapeutic oncotarget for cancer prevention
- (2016) Wang Zhiyu et al. Oncotarget
- Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells
- (2016) Lu Han et al. Journal of Immunology Research
- Natural killer cell immunotherapy to target stem-like tumor cells
- (2016) Steven K. Grossenbacher et al. Journal for ImmunoTherapy of Cancer
- Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer
- (2015) Faruk Tas et al. BIOMEDICINE & PHARMACOTHERAPY
- Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma
- (2015) Xuan Zhao et al. CANCER LETTERS
- Inflammation Fuels Tumor Progress and Metastasis
- (2015) Jingyi Liu et al. CURRENT PHARMACEUTICAL DESIGN
- Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives
- (2015) Lidia Giraudo et al. Immunotherapy
- Immunity, inflammation, and cancer: an eternal fight between good and evil
- (2015) Shabnam Shalapour et al. JOURNAL OF CLINICAL INVESTIGATION
- MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer
- (2015) Zibing Wang et al. Oncotarget
- Context-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
- (2014) Marina Fabbi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cancer-related inflammation and treatment effectiveness
- (2014) Connie I Diakos et al. LANCET ONCOLOGY
- Inflammasomes
- (2014) M. R. de Zoete et al. Cold Spring Harbor Perspectives in Biology
- Clinical Implications of VEGF, TGF-beta1, and IL-1beta in Patients with Advanced Non-small Cell Lung Cancer
- (2014) Ji-Won Kim et al. Cancer Research and Treatment
- The Epidemiology of Pancreatitis and Pancreatic Cancer
- (2013) Dhiraj Yadav et al. GASTROENTEROLOGY
- 3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome
- (2013) Yuan He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression
- (2013) Qing Wei et al. LABORATORY INVESTIGATION
- Regulation of inflammasome signaling
- (2012) Vijay A K Rathinam et al. NATURE IMMUNOLOGY
- Two Hundred Years of Cancer Research
- (2012) Vincent T. DeVita et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of the Innate Immunity and Inflammation Pathway with Advanced Prostate Cancer Risk
- (2012) Rémi Kazma et al. PLoS One
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells
- (2010) Yeon Jin Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- The Inflammasome Component Nlrp3 Impairs Antitumor Vaccine by Enhancing the Accumulation of Tumor-Associated Myeloid-Derived Suppressor Cells
- (2010) H. W. van Deventer et al. CANCER RESEARCH
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
- (2009) Matthew H. G. Katz et al. ANNALS OF SURGICAL ONCOLOGY
- IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor Survival
- (2009) Anna Carbone et al. JOURNAL OF IMMUNOTHERAPY
- Improving treatment of pancreatic cancer
- (2008) Philip A Philip LANCET ONCOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started